Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Albany, GA MSA — October 2026
Albany's Regulatory Affairs pay climbs as manufacturing talent pool thins.
Albany's Regulatory Affairs Specialist pay hit $108,529 against a softening national median of $103,780, even as statewide pharma manufacturing job openings sit at just 367 against 1,700-plus new roles promised by a single Athens-Clarke County expansion.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Albany metro unemployment: 4.1% — vs 3.3% Georgia statewide (Aug 2026)
- Regulatory Affairs Specialist pay: $108,529 metro — vs $103,780 national, trending down
- Statewide pharma manufacturing openings: 367 jobs — vs 1,700+ jobs pledged by single Athens expansion
- Albany nonfarm employment: -1.2% YoY — Govt. (-2.6%) and retail (-2.8%) contracting
Key takeaways
Regulatory Affairs pay in Albany now outpaces the national figure.
Metro median of $108,529 against a national $103,780 that is drifting down signals Albany employers are holding the line on regulatory compensation even as national demand softens slightly. Credential scarcity appears to be setting this rate.
Biostatistician pay growth outruns the national trend here.
Metro median $135,548 moving up against a flat national $131,958 suggests Albany-based employers are paying a premium to secure or retain data-focused specialists locally, favoring that approach over reliance on remote or outsourced analytics talent.
Lab Technician pay is sliding while national rates hold firm.
Metro median down to $43,680 against a stable national $47,840 is consistent with Albany's broader retail and government contraction pulling entry-level wage pressure downward even as specialized roles pull in the opposite direction.
Thin statewide manufacturing openings strengthen the case for CDMO reliance.
Only 367 open pharma manufacturing jobs statewide, against 1,700-plus new jobs promised by the Meissner Corp facility alone, implies Albany-area employers may struggle to in-source biomanufacturing capacity and should model CDMO costs against local hiring timelines now.
Median advertised pay by role — Albany, GA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $81,692 | $98,193 | $129,087 | Moderate increase | $130,339 |
| Clinical Research Associate * | $61,257 | $81,815 | $99,066 | Significant increase | $90,065 |
| Lab Technician * | $37,646 | $43,680 | $52,000 | Moderate decline | $47,840 |
| Regulatory Affairs Specialist * | $71,138 | $108,529 | $116,373 | Stable | $103,780 |
| Clinical Data Manager * | $97,384 | $117,653 | $128,800 | Stable | $123,653 |
| Biostatistician * | $93,101 | $135,548 | $137,613 | Moderate increase | $131,958 |
| Validation Engineer * | $94,494 | $105,161 | $127,663 | Moderate increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Albany's metro unemployment held at 4.1% in August against Georgia's 3.3%, with nonfarm employment contracting 1.2% year-over-year as retail trade and government — nearly a fifth of all metro jobs — continue to shed positions. A heavily public-sector economy with an $22.90 average pharma manufacturing hourly wage statewide leaves Albany structurally exposed when national biopharma hiring momentum returns and specialized talent gravitates toward higher-paying hubs.
What it means
Georgia's pharma manufacturing pay floor sits well below competitive biotech markets, which compounds the national bottleneck in CMC, biomanufacturing, and regulatory talent documented this month — Albany employers compete for the same scarce credentialed workers as Athens-Clarke County's Meissner Corp expansion and Johns Creek's Boston Scientific R&D hub, both offering more scale and visibility. Statewide pharma manufacturing job openings remain thin (367 total) even as R&D roles grew 44% from 2019–2022, suggesting build-vs-outsource decisions in Albany increasingly favor CDMO partnerships over in-house quality and manufacturing buildout. Organizations should evaluate whether current compensation structures for regulatory affairs and biomanufacturing roles reflect the full statewide talent competition created by Athens and Johns Creek expansions, including pressures beyond Albany's own wage history.
Looking ahead
Potential inflection point: Watch whether Meissner Corp's Athens-Clarke County buildout and Boston Scientific's Johns Creek expansion begin drawing regulatory and manufacturing talent out of Albany-area employers over the next two quarters, tightening an already thin specialist pool.
Emerging pressure point: Albany's 4.1% unemployment sitting a full point above Georgia's 3.3% rate, combined with contracting retail and government employment, may push displaced workers toward life sciences manufacturing and quality roles if reskilling pathways develop locally.
Worth watching: National quit rate holding at 1.9% means experienced CRAs and CMC specialists are staying put even as 64% of biopharma organizations report active recruiting — watch whether Albany employers need to raise advertised pay further to dislodge passive candidates from competitors.
Early indicator: Wellstar Health System's 761-worker WARN filing and Essendant's 192-worker closure add to Georgia's layoff volume this quarter — monitor whether any affected workers carry transferable quality, regulatory, or clinical operations skills into the Albany life sciences labor pool.
Sources
- Georgia Department of Labor / BLS — Albany metro unemployment at 4.1% vs Georgia 3.3% statewide
- USA Facts / BLS — Albany nonfarm employment contracted 1.2% year-over-year
- Georgia Department of Labor — Georgia pharma manufacturing hourly pay averages $22.90
- Georgia Life Sciences Manufacturing Council — Meissner Corp 1,700+ job facility in Athens-Clarke County
- Georgia Department of Labor — Only 367 open pharma manufacturing jobs statewide
- Industry labor market survey — National quit rate at 1.9% amid active biopharma recruiting
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.